Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Nitroprusside Sodium
The First People's Hospital of Lianyungang
ST Segment Elevation Myocardial Infarction
1 trial -
Peginterferon Ξ±-2b injection
The First People's Hospital of Lianyungang
Condylomata Acuminata
1 trial -
Percutaneous transhepatic biliary stenting with conventional linear ^125^I seeds strand
The First People's Hospital of Lianyungang
Malignant Obstructive Jaundice
1 trial -
Personalized Functional Profiling
Universal Integrated
Oncology
1 trial -
Pioglitazone
Takeda
HIV Infections
1 trial -
Placebo
Regeneron Ireland Designated Activity Company (DAC)
Knee Osteoarthritis
1 trial -
Placebo 1 to Probiotic A
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastrointestinal Dysfunction
1 trial -
Prediction Model Arm
The First People's Hospital of Lianyungang
Lung Cancer Screening
1 trial -
Prediction of intraoperative hypothermia risk
The First People's Hospital of Lianyungang
Intraoperative Hypothermia
1 trial -
Prednisone
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Undifferentiated Connective Tissue Disease
1 trial -
Preoperative three-dimensional reconstruction
Universal Integrated
Kidney Neoplasms / Surgery
1 trial -
Probiotics
BRIGHT MINDS BIOSCIENCES INC.
HIV Infection
1 trial -
Qingre Huashi Granules combined the modified dual therapy
The First People's Hospital of Lianyungang
Helicobacter Pylori Infection
1 trial -
REMIMAZOLAM BESYLATE 2.5 Mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, for SOLUTION [BYFAVO]
Hospital Authority, Hong Kong
Hemodynamic Instability
1 trial -
RSV A Memphis 37
United Therapeutics Europe Ltd
Respiratory Syncytial Virus Infections
1 trial -
Reduction CTVp1
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nasopharyngeal Carcinoma
1 trial -
Regen Matrix-PRP-XLHA
Regeneron Ireland Designated Activity Company (DAC)
Knee Osteoarthritis
1 trial -
Regional lymph node radiotherapy (RNI) including the axilla
The First People's Hospital of Lianyungang
Axillary Lymph Node Dissection
1 trial -
Rituximab, Methotrexate, and Thiotepa (R-MT) Induction Followed by Etoposide and Cytarabine (EA) Consolidation
The First People's Hospital of Lianyungang
Primary Central Nervous System Lymphoma (PCNSL)
1 trial -
SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/ Serotonin and Norepinephrine Reuptake Inhibitors)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Major Depressive Disorder
1 trial -
Selective Serotonin Reuptake Inhibitors (SSRIs)
The First People's Hospital of Lianyungang
Major Depressive Disorder
1 trial -
Seromycin (D-cycloserine, DCS)
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Addiction
1 trial -
Sitz-Markers
United Therapeutics Europe Ltd
Return of Bowel Function After Colon Surgery
1 trial -
Sivelestat
The First People's Hospital of Lianyungang
Aortic Dissection
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources